Among those five E2F targets correlated with malignant transition, Cdk1 and Plk1 were well studied in breast cancer, but much less so for Ccnb2, Aurkb, and Spag5 (7, 10, and 3 reports, respectively). Here, SPAG5 is linked to breast carcinoma.